FDA Inspection 1219066 — Igor Chaplik, D.O.
The FDA completed an inspection of Igor Chaplik, D.O. on August 25, 2023 in Fort Lauderdale, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 25, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Fort Lauderdale, FL (United States)
Additional Details
Clinical BA/BE